TrkA Expression as a Novel Prognostic Biomarker in Oral Squamous Cell Carcinoma
Abstract
1. Introduction
2. Results
2.1. Expression of Trk Proteins and Clinicopathological Correlations
2.2. Survival Analysis
2.3. NTRK Gene Expression Correlations
3. Discussion
4. Materials and Methods
4.1. Study Population and Clinical Data
4.2. Tissue Processing and Immunohistochemistry
4.3. Molecular Analysis
4.4. Statistical Analysis
5. Conclusions
Limitations of This Study
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Nijakowski, K.; Gruszczyński, D.; Kopała, D.; Surdacka, A. Salivary Metabolomics for Oral Squamous Cell Carcinoma Diagnosis: A Systematic Review. Metabolites 2022, 12, 294. [Google Scholar] [CrossRef] [PubMed]
- Muller, S.; Tilakaratne, W.M. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Tumours of the Oral Cavity and Mobile Tongue. Head Neck Pathol. 2022, 16, 54–62. [Google Scholar] [CrossRef] [PubMed]
- Maymone, M.B.C.; Greer, R.O.; Kesecker, J.; Sahitya, P.C.; Burdine, L.K.; Cheng, A.-D.; Maymone, A.C.; Vashi, N.A. Premalignant and malignant oral mucosal lesions: Clinical and pathological findings. J. Am. Acad. Dermatol. 2019, 81, 59–71. [Google Scholar] [CrossRef] [PubMed]
- Telugu, R.B.; Gaikwad, P.; Baitule, A.; Michael, R.C.; Mani, T.; Thomas, M. Myoepithelial Tumors of Salivary Gland: A Clinicopathologic and Immunohistochemical Study of 15 Patients with MIB-1 Correlation. Head Neck Pathol. 2021, 15, 479–490. [Google Scholar] [CrossRef] [PubMed]
- Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef] [PubMed]
- Johnson, D.E.; Burtness, B.; Leemans, C.R.; Lui, V.W.Y.; Bauman, J.E.; Grandis, J.R. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Primers 2020, 6, 92. [Google Scholar] [CrossRef] [PubMed]
- Chamoli, A.; Gosavi, A.S.; Shirwadkar, U.P.; Wangdale, K.V.; Behera, S.K.; Kurrey, N.K.; Kalia, K.; Mandoli, A. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncol. 2021, 121, 105451. [Google Scholar] [CrossRef] [PubMed]
- Al Feghali, K.A.; Ghanem, A.I.; Burmeister, C.; Chang, S.S.; Ghanem, T.; Keller, C.; Siddiqui, F. Impact of smoking on pathological features in oral cavity squamous cell carcinoma. J. Cancer Res. Ther. 2019, 15, 582–588. [Google Scholar] [CrossRef] [PubMed]
- Katirachi, S.K.; Grønlund, M.P.; Jakobsen, K.K.; Grønhøj, C.; von Buchwald, C. The Prevalence of HPV in Oral Cavity Squamous Cell Carcinoma. Viruses 2023, 15, 451. [Google Scholar] [CrossRef] [PubMed]
- Saleem, M.W.; Baig, F.A.; Hadi, N.I. A novel comparison of Epstein-Barr virus with broad histological spectrum of oral squamous cell carcinoma. Pak. J. Med. Sci. 2019, 35, 1192. [Google Scholar] [CrossRef] [PubMed]
- Zebardast, A.; Yahyapour, Y.; Majidi, M.S.; Chehrazi, M.; Sadeghi, F. Detection of Epstein-Barr virus encoded small RNA genes in oral squamous cell carcinoma and non-cancerous oral cavity samples. BMC Oral Health 2021, 21, 502. [Google Scholar] [CrossRef] [PubMed]
- Khalesi, S.; Khalesi, S.; Ghapani, F. Evaluation of Epstein-Barr virus expression in oral squamous cell carcinomas. Dent. Res. J. 2022, 19, 58. [Google Scholar]
- Ramos, J.C.; Alves, F.A.; Kowalski, L.P.; dos Santos-Silva, A.R.; Vargas, P.A.; Lopes, M.A. Epidemiological profile and clinical implications of oral squamous cell carcinoma adjacent to dental implants. Oral Dis. 2021, 27, 1687–1698. [Google Scholar] [CrossRef] [PubMed]
- Afrashtehfar, K.I.; Almomani, M.M.; Momani, M. Lack of association between dental implants and oral squamous cell carcinoma. Evid.-Based Dent. 2022, 23, 40–42. [Google Scholar] [CrossRef] [PubMed]
- Zanoni, D.K.; Demétrio De Souza França, P.; Valero, C.; Peterson, G.; Ardigo, M.; Ghossein, R.; Dusza, S.W.; Matsuura, D.; Scholfield, D.W.; Adilbay, D.; et al. A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for In Vivo Assessment in Oral Cancer. Clin. Cancer Res. 2024, 30, 2486–2496. [Google Scholar] [CrossRef] [PubMed]
- Tan, Y.; Wang, Z.; Xu, M.; Li, B.; Huang, Z.; Qin, S.; Nice, E.C.; Tang, J.; Huang, C. Oral squamous cell carcinomas: State of the field and emerging directions. Int. J. Oral Sci. 2023, 15, 14. [Google Scholar] [CrossRef] [PubMed]
- Massano, J.; Regateiro, F.S.; Januário, G.; Ferreira, A. Oral squamous cell carcinoma: Review of prognostic and predictive factors. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol. 2006, 102, 67–76. [Google Scholar] [CrossRef] [PubMed]
- Ferreira, A.K.; Carvalho, S.; Granville-Garcia, A.; Sarmento, D.; Agripino, G.; Abreu, M.; Melo, M.; Caldas, A.D., Jr.; Godoy, G. Survival and prognostic factors in patients with oral squamous cell carcinoma. Med. Oral Patol. Oral Cir. Bucal 2021, 26, e387. [Google Scholar] [CrossRef] [PubMed]
- Eljabo, N.; Nikolic, N.; Carkic, J.; Jelovac, D.; Lazarevic, M.; Tanic, N.; Milasin, J. Genetic and epigenetic alterations in the tumour, tumour margins, and normal buccal mucosa of patients with oral cancer. Int. J. Oral Maxillofac. Surg. 2018, 47, 976–982. [Google Scholar] [CrossRef] [PubMed]
- Adamski, Ł.J.; Starzyńska, A.; Adamska, P.; Kunc, M.; Sakowicz-Burkiewicz, M.; Marvaso, G.; Alterio, D.; Korwat, A.; Jereczek-Fossa, B.A.; Pęksa, R. High PD-L1 Expression on Tumor Cells Indicates Worse Overall Survival in Advanced Oral Squamous Cell Carcinomas of the Tongue and the Floor of the Mouth but Not in Other Oral Compartments. Biomedicines 2021, 9, 1132. [Google Scholar] [CrossRef] [PubMed]
- Nocini, R.; Vianini, M.; Girolami, I.; Calabrese, L.; Scarpa, A.; Martini, M.; Morbini, P.; Marletta, S.; Brunelli, M.; Molteni, G.; et al. PD-L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside. Clin. Exp. Dent. Res. 2022, 8, 690–698. [Google Scholar] [CrossRef] [PubMed]
- Jiang, T.; Wang, G.; Liu, Y.; Feng, L.; Wang, M.; Liu, J.; Chen, Y.; Ouyang, L. Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers. Acta Pharm. Sin. B 2021, 11, 355–372. [Google Scholar] [CrossRef] [PubMed]
- Cocco, E.; Scaltriti, M.; Drilon, A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat. Rev. Clin. Oncol. 2018, 15, 731–747. [Google Scholar] [CrossRef] [PubMed]
- Nguyen, M.A.; Colebatch, A.J.; Van Beek, D.; Tierney, G.; Gupta, R.; Cooper, W.A. NTRK fusions in solid tumours: What every pathologist needs to know. Pathology 2023, 55, 596–609. [Google Scholar] [CrossRef] [PubMed]
- Han, L.; Zhang, Z.; Qin, W.; Sun, W. Neurotrophic receptor TrkB: Is it a predictor of poor prognosis for carcinoma patients? Med. Hypotheses 2007, 68, 407–409. [Google Scholar] [CrossRef] [PubMed]
- Segal, R.A. Selectivity in neurotrophin signaling: Theme and variations. Annu. Rev. Neurosci. 2003, 26, 299–330. [Google Scholar] [CrossRef] [PubMed]
- Jin, W. Roles of TrkC Signaling in the Regulation of Tumorigenicity and Metastasis of Cancer. Cancers 2020, 12, 147. [Google Scholar] [CrossRef] [PubMed]
- Sasahira, T.; Ueda, N.; Yamamoto, K.; Bhawal, U.K.; Kurihara, M.; Kirita, T.; Kuniyasu, H. Trks are novel oncogenes involved in the induction of neovascularization, tumor progression, and nodal metastasis in oral squamous cell carcinoma. Clin. Exp. Metastasis 2013, 30, 165–176. [Google Scholar] [CrossRef] [PubMed]
- Escoto-Vasquez, L.S.; Portilla-Robertson, J.; Ramírez-Jarquín, J.O.; Jacinto-Alemán, L.F.; Alonso-Moctezuma, A.; Ramírez-Martínez, C.M.; Chanes-Cuevas, O.A.; Salgado-Chavarria, F. NTRK Gene Expression Analysis in Oral Squamous Cell Carcinoma Mexican Population. Dent. J. 2024, 12, 327. [Google Scholar] [CrossRef] [PubMed]
- Huang, E.J.; Reichardt, L.F. Trk receptors: Roles in neuronal signal transduction. Annu. Rev. Biochem. 2003, 72, 609–642. [Google Scholar] [CrossRef] [PubMed]
- Kaplan, D.R.; Miller, F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 2000, 10, 381–391. [Google Scholar] [CrossRef] [PubMed]
- Conde, E.; Sanchez, E.; Regojo, R.M.; Camacho, C.; Alonso, M.; Martinez, R.; Lopez-Rios, F. Pan-TRK immunohistochemistry an example-based practical approach to efficiently identify patients with NTRK fusion cancer. Arch. Pathol. Lab. Med. 2021, 145, 1031–1040. [Google Scholar] [CrossRef] [PubMed]
- Durzyńska, M.; Michałek, I.M. Pan-TRK immunohistochemistry as a tool in the screening for NTRK gene fusions in cancer patients. Oncol. Clin. Pract. 2024, 20, 15–21. [Google Scholar] [CrossRef]
- Cho, Y.A.; Chung, J.M.; Ryu, H.; Kim, E.K.; Cho, B.C.; Yoon, S.O. Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical implications and possible roles of human papillomavirus infection. Cancer Res. Treat. 2019, 51, 1052–1063. [Google Scholar] [CrossRef] [PubMed]
- Faulkner, S.; Griffin, N.; Rowe, C.W.; Jobling, P.; Lombard, J.M.; Oliveira, S.M.; Walker, M.M.; Hondermarck, H. Nerve growth factor and its receptor tyrosine kinase TrkA are overexpressed in cervical squamous cell carcinoma. FASEB BioAdv. 2020, 2, 398–408. [Google Scholar] [CrossRef] [PubMed]
- Yu, Z.; Wang, H.; Song, Q.; Huang, J.; Xu, J.; Su, J.; Wang, H.; Tan, L.; Wang, X.; Jiang, Z.; et al. Prognostic value and characterization of NTRK1 variation by fluorescence in situ hybridization in esophageal squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 2021, 147, 3113–3121. [Google Scholar] [CrossRef] [PubMed]
- Terry, J.; De Luca, A.; Leung, S.; Peacock, G.; Wang, Y.; Elliot, W.M.; Huntsman, D. Immunohistochemical expression of neurotrophic tyrosine kinase receptors 1 and 2 in lung carcinoma: Potential discriminators between squamous and nonsquamous subtypes. Arch. Pathol. Lab. Med. 2011, 135, 433–439. [Google Scholar] [CrossRef] [PubMed]
Feature | TrkA High | TrkA Low | p | TrkB High | TrkB Low | p | TrkC High | TrkC Low | p | |
---|---|---|---|---|---|---|---|---|---|---|
Gender | Female | 23 | 8 | 0.217 | 14 | 17 | 0.767 | 4 | 27 | 0.682 |
Male | 38 | 24 | 26 | 36 | 10 | 52 | ||||
Grade | High | 31 | 24 | 0.024 | 24 | 31 | 0.883 | 10 | 45 | 0.310 |
Low | 30 | 8 | 16 | 22 | 4 | 34 | ||||
Stage | High | 28 | 16 | 0.507 | 19 | 25 | 0.502 | 6 | 38 | 0.321 |
Low | 22 | 9 | 11 | 20 | 2 | 29 | ||||
pN | 0–1 | 29 | 9 | 0.112 | 13 | 21 | 0.902 | 5 | 29 | 0.060 |
2–3 | 20 | 14 | 14 | 24 | 1 | 37 | ||||
pT | 1–2 | 29 | 11 | 0.325 | 15 | 19 | 0.423 | 5 | 29 | 0.319 |
3–4 | 21 | 13 | 14 | 26 | 3 | 37 | ||||
Localization | Other | 24 | 14 | 0.681 | 14 | 24 | 0.317 | 7 | 31 | 0.450 |
* | 37 | 18 | 26 | 29 | 7 | 48 | ||||
Tobacco | No | 15 | 7 | 0.919 | 9 | 13 | 0.878 | 2 | 20 | 0.697 |
Yes | 34 | 15 | 21 | 28 | 6 | 43 | ||||
Alcohol | No | 37 | 29 | 0.052 | 20 | 37 | 0.024 | 7 | 50 | 0.640 |
Yes | 12 | 1 | 9 | 4 | 1 | 12 |
Feature | TrkA p-Value | TrkB p-Value | TrkC p-Value |
---|---|---|---|
Gender | 0.177 | 0.899 | 0.733 |
Death | 0.299 | 0.686 | 0.513 |
Grade | 0.014 | 0.499 | 0.587 |
Stage | 0.659 | 0.428 | 0.601 |
pT | 0.406 | 0.922 | 0.625 |
pN | 0.213 | 0.330 | 0.382 |
Localization * | 0.784 | 0.347 | 0.639 |
Feature | Number of Cases | % | |
---|---|---|---|
Gender | Female | 31 | 33.3 |
Male | 62 | 66.7 | |
Patient outcome: death | No | 69 | 74.2 |
Yes | 24 | 25.8 | |
Grade | 1 | 38 | 40.9 |
2 | 45 | 48.4 | |
3 | 10 | 10.7 | |
Stage | I | 16 | 17.2 |
II | 15 | 16.1 | |
III | 13 | 14 | |
IV | 31 | 33.3 | |
pT | 1 | 16 | 17.2 |
2 | 24 | 25.8 | |
3 | 14 | 15 | |
4 | 20 | 21.5 | |
No data | 19 | 20.4 | |
pN | 0 | 38 | 40.9 |
1 | 11 | 11.8 | |
2 | 17 | 18.3 | |
3 | 6 | 6.5 | |
No data | 21 | 22.6 | |
Surgical treatment | No | 21 | 22.6 |
Yes | 80 | 63.4 | |
No data | 13 | 14 | |
Radiotherapy | No | 32 | 34.4 |
Yes | 42 | 45.2 | |
No data | 19 | 20.4 | |
Chemotherapy | No | 65 | 69.9 |
Yes | 9 | 9.7 | |
No data | 19 | 20.4 | |
Localization of the tumor | Tongue/Oral cavity floor | 55 | 59.1 |
Other | 38 | 40.9 | |
Tobacco use | No | 22 | 23.6 |
Yes | 49 | 52.7 | |
No data | 22 | 23.7 | |
Alcohol consumption | No | 57 | 61.3 |
Yes | 13 | 14 | |
No data | 23 | 24.7 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ciarka, A.; Skowronek, F.; Miłosz, P.; Kunc, M.; Burdach, R.; Sakowicz-Burkiewicz, M.; Jereczek-Fossa, B.; Starzyńska, A.; Pęksa, R. TrkA Expression as a Novel Prognostic Biomarker in Oral Squamous Cell Carcinoma. Int. J. Mol. Sci. 2025, 26, 6847. https://doi.org/10.3390/ijms26146847
Ciarka A, Skowronek F, Miłosz P, Kunc M, Burdach R, Sakowicz-Burkiewicz M, Jereczek-Fossa B, Starzyńska A, Pęksa R. TrkA Expression as a Novel Prognostic Biomarker in Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2025; 26(14):6847. https://doi.org/10.3390/ijms26146847
Chicago/Turabian StyleCiarka, Aleksandra, Filip Skowronek, Przemysław Miłosz, Michał Kunc, Robert Burdach, Monika Sakowicz-Burkiewicz, Barbara Jereczek-Fossa, Anna Starzyńska, and Rafał Pęksa. 2025. "TrkA Expression as a Novel Prognostic Biomarker in Oral Squamous Cell Carcinoma" International Journal of Molecular Sciences 26, no. 14: 6847. https://doi.org/10.3390/ijms26146847
APA StyleCiarka, A., Skowronek, F., Miłosz, P., Kunc, M., Burdach, R., Sakowicz-Burkiewicz, M., Jereczek-Fossa, B., Starzyńska, A., & Pęksa, R. (2025). TrkA Expression as a Novel Prognostic Biomarker in Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences, 26(14), 6847. https://doi.org/10.3390/ijms26146847